Century Pharmalabs India Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 2.00 M
as on 16-11-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.92 Cr
as on 16-11-2024
- Satisfied Charges ₹ 8.00 M
as on 16-11-2024
- Revenue -6.57%
(FY 2023)
- Profit -25.80%
(FY 2023)
- Ebitda -23.08%
(FY 2023)
- Net Worth 9.08%
(FY 2023)
- Total Assets 36.56%
(FY 2023)
About Century Pharmalabs India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.92 Cr. The company has closed loans amounting to ₹8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Vallamkonda, Sesha Bondada, Venkata Bondada, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232AP2013PTC088745
- Company No.
088745
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Century Pharmalabs India Private Limited offer?
Century Pharmalabs India Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiviral Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines.
Who are the key members and board of directors at Century Pharmalabs India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Vallamkonda  | Managing Director | 02-Jul-2013 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sesha Bondada | Director | 13-Mar-2018 | Current |
| Venkata Bondada | Additional Director | 04-Oct-2024 | Current |
| Ashalatha Bondada | Additional Director | 04-Oct-2024 | Current |
Financial Performance of Century Pharmalabs India.
Century Pharmalabs India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.57% decrease. The company also saw a substantial fall in profitability, with a 25.8% decrease in profit. The company's net worth moved up by a moderate rise of 9.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Century Pharmalabs India?
In 2022, Century Pharmalabs India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 04 Dec 2018 | ₹3.92 Cr | Open |
Others Creation Date: 22 May 2017 | ₹8.00 M | Satisfied |
How Many Employees Work at Century Pharmalabs India?
Unlock and access historical data on people associated with Century Pharmalabs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Century Pharmalabs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Century Pharmalabs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
